This article is more than 5 years old. Information may no longer be current.

Optovue raises $10.5 million in venture capital

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

FREMONT, Calif. — Optovue, maker of the RTVue Fourier-domain optical coherence tomography system, has received $10.5 million in Series B funding, the company announced in a press release.

Venture capital firm Trevi Health Ventures led the investment, followed by several partners from Optovue's previous funding round. The money will expand production of the RTVue, which was recently released outside the United States, as well as advance the development of the company's product pipeline, the release said.

Optovue also appointed John Moore, former president of Zeiss Humphrey Systems, to its board of directions, according to the release.